Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

apixaban

apixaban
Brand names: Eliquis
Form Strength
TABLET, ORAL 2.5 mg; 5 mg


Additional Information:
Drug Name Common Side Effects

Apixaban

  • bleeding
  • bruising
  • nausea

Anticoagulation Therapy Management: Policy 900.3207

Clinical Guidelines:

Initiation/Dosing: Anticoagulation selection for patients with non-valvular atrial fibrillation. See Guideline 900.5008

Initiation/Other: Direct Oral Anticoagulant Use for Venous Thromboembolism, see Protocol 900.5206

Transitioning: Warfarin transition (to or from apixaban): See Guideline 900.5863

Surgery: Timing of Neuraxial Anesthesia and Anticoagulation: See Guideline 900.5681

Surgery: Periprocedural Management of Anticoagulation therapy: See Protocol 900.5011

Reversal: Reversal in bleeding patients or for emergent surgery: See Reversal Guideline 900.5010

Antithrombotic and Anticoagulant Treatment in Stroke: See 900.5018

 Free 30-Day trial or $10 co-pay Coupons available electronically for Legacy Health

 


Last updated: Jan. 17, 2022







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.